2seventy Bio
(NASDAQ) TSVT
2seventy Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$48.37M
Net Income (TTM)
$4.09M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
TSVT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 2seventy Bio
Industry
Biotechnology
Sector
Health CareEmployees
65
CEO
Chip Baird, III, MBA
Website
www.2seventybio.comHeadquarters
Cambridge, MA 02142, US
TSVT Financials
Key Financial Metrics (TTM)
Gross Margin
46%
Operating Margin
-100%
Net Income Margin
-74%
Return on Equity
-9%
Return on Capital
-6%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$15.30M
Operating Income
$115.43M
EBITDA
$98.45M
Operating Cash Flow
$85.00M
Capital Expenditure
$707.00K
Free Cash Flow
$85.70M
Cash & ST Invst.
$174.75M
Total Debt
$243.72M
2seventy Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$22.94M
+84.5%
Gross Profit
$17.79M
+205.1%
Gross Margin
77.54%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
65
N/A
Net Income
$482.00K
+100.9%
EBITDA
$825.00K
+98.2%
Quarterly Fundamentals
Net Cash
$69.39M
+3.2%
Accounts Receivable
$23.93M
+99.8%
Inventory
$0.00
N/A
Long Term Debt
$223.00M
-7.1%
Short Term Debt
$33.52M
+28.9%
Return on Assets
-3.97%
N/A
Return on Invested Capital
-5.88%
N/A
Free Cash Flow
$10.97M
+74.2%
Operating Cash Flow
$10.97M
+73.8%